GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,740,000 | +0.8% | 39,977 | +0.8% | 0.40% | +14.0% |
| Q1 2022 | $1,727,000 | +2.9% | 39,646 | +4.2% | 0.35% | +5.1% |
| Q4 2021 | $1,678,000 | +15.3% | 38,055 | -0.1% | 0.33% | +5.4% |
| Q3 2021 | $1,455,000 | -24.3% | 38,089 | -21.0% | 0.32% | -22.4% |
| Q2 2021 | $1,921,000 | +128.4% | 48,242 | +104.6% | 0.41% | +119.5% |
| Q1 2021 | $841,000 | +4.5% | 23,574 | +7.8% | 0.18% | -3.1% |
| Q4 2020 | $805,000 | +2.4% | 21,870 | +4.7% | 0.19% | -12.0% |
| Q3 2020 | $786,000 | -10.5% | 20,883 | -3.0% | 0.22% | -14.2% |
| Q2 2020 | $878,000 | +7.3% | 21,535 | -0.3% | 0.25% | -6.3% |
| Q1 2020 | $818,000 | -19.1% | 21,593 | +0.4% | 0.27% | +2.7% |
| Q4 2019 | $1,011,000 | +9.5% | 21,517 | -0.5% | 0.26% | +3.1% |
| Q3 2019 | $923,000 | +8.2% | 21,630 | +1.5% | 0.26% | +5.4% |
| Q2 2019 | $853,000 | -3.8% | 21,317 | +0.4% | 0.24% | -4.3% |
| Q1 2019 | $887,000 | +10.6% | 21,228 | +1.1% | 0.25% | -4.2% |
| Q4 2018 | $802,000 | – | 20,997 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |